South Africa became the first country to roll out the Johnson&Johnson vaccine.
The vaccination roll out started last week Wednesday after the vaccine arrived in the country on Tuesday and the vaccination started with healthcare workers.The vaccine has also proven to be more effective than the innitial data had shown.
The first batch of 80 000 of Johnson&Johnson arrived after the Astrazeneca vaccine that was delivered from the Serum Institute of India was found to have a low efficacy against the virus 501Y.V2 variant. The vaccine was sold to the African Union.
South Africa participated in a Johnson&Johnson vaccine trial with more than 5 000 participant and no one had died during this time. Half of the participants were given a blacebo. The J&J vaccine has also proven to be effective on the new variant.
The country will be receiving another 80 000 batch of the Johnson& Johnson vaccine on Saturday.
Content created and supplied by: Phukubjenthaa (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More